Karel Cwiertka

Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study

Paul Sabbatini, Philipp Harter, Giovanni Scambia et al. · Journal of Clinical Oncology · 2013 · 145 citations · Full text

Medicine, Gynecology, Oncology +16

Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial

Matthias Löhr, Stephan Haas, Wolf O. Bechstein et al. · Annals of Oncology · 2011 · 105 citations · Full text

Medicine, Oncology, Pharmacology +13

An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer

Giuseppe Capri, José Chang, S.-C. Chen et al. · Annals of Oncology · 2009 · 87 citations · Full text

Medicine, Oncology, Pharmacology +14

BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy

Kateřina Bouchalová, Marek Svoboda, Gvantsa Kharaishvili et al. · Tumor Biology · 2015 · 37 citations

Medicine, Cancer Biology, Oncology +17

Targeting genotoxic and proteotoxic stress‐response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram

Dušana Majera, Zdeněk Škrott, Jan Bouchal et al. · The Prostate · 2018 · 32 citations

Medicine, Oncology, Pharmacology +16